SDC1 and plasma cell myeloma: Specifically, we assessed the chromatin accessibility of primary CD138+ plasma cells from two relapsed myeloma patients following treatment with bortezomib, and confirmed a significant enhancement in the intensity of the ATAC‐seq signal at the transcription start site (TSS) regions of the SEI1 gene (Figure 4F).